Cargando…
Extracellular Vesicle Encapsulated MicroRNAs in Patients with Type 2 Diabetes Are Affected by Metformin Treatment
Recently, microRNAs (miRNAs) in circulating extracellular vesicles (EVs), have emerged as a source of potential biomarkers for various pathophysiological conditions, including metabolic disorders such as diabetes. Type 2 diabetes mellitus (T2DM), is the most prevalent form of diabetes in the USA, wi...
Autores principales: | Ghai, Vikas, Kim, Taek-Kyun, Etheridge, Alton, Nielsen, Trine, Hansen, Torben, Pedersen, Oluf, Galas, David, Wang, Kai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6571700/ https://www.ncbi.nlm.nih.gov/pubmed/31067715 http://dx.doi.org/10.3390/jcm8050617 |
Ejemplares similares
-
Genome-wide Profiling of Urinary Extracellular Vesicle microRNAs Associated With Diabetic Nephropathy in Type 1 Diabetes
por: Ghai, Vikas, et al.
Publicado: (2017) -
Role of MicroRNAs in Renal Parenchymal Diseases—A New Dimension
por: Shaffi, Saeed Kamran, et al.
Publicado: (2018) -
The Impact of Extracellular Vesicle-Encapsulated Circulating MicroRNAs in Lung Cancer Research
por: Fujita, Yu, et al.
Publicado: (2014) -
Immune Modulation Using Extracellular Vesicles Encapsulated with MicroRNAs as Novel Drug Delivery Systems
por: Matsuzaka, Yasunari, et al.
Publicado: (2022) -
MicroRNAs in Extracellular Vesicles of Alzheimer’s Disease
por: Li, Wanran, et al.
Publicado: (2023)